COVID-19或流感住院后一年内神经科医疗负担与新发神经诊断
本研究基于TriNetX电子健康记录数据,对77,272例COVID-19与77,272例流感住院成人进行1:1倾向评分匹配,比较其后一年内6类神经诊断的医疗就诊和新发诊断风险。结果显示COVID-19组新发神经诊断风险低于流感组(2.79% vs 4.91%,HR 0.618,95%CI 0.582-0.657),各单项神经诊断就诊风险亦均较低。
要点
- COVID-19组新发神经诊断2.79%,低于流感组4.91%(HR 0.618,95%CI 0.582-0.657)。
- COVID-19组偏头痛、癫痫、神经病、运动障碍、卒中、痴呆就诊风险均低于流感组。
- 研究为基于电子健康记录的匹配队列分析,结论需结合原文局限性解读。
核心结论
- 与匹配的流感住院或急诊成人相比,COVID-19患者一年随访内6类主要神经诊断的医疗就诊显著更少。
- COVID-19感染与感染后一年内新发神经诊断风险较低相关。
研究设计与样本
- 基于TriNetX全球健康研究网络去标识化电子健康记录的患者层面数据分析。
- 纳入索引事件时年龄≥18岁者,索引事件定义为因COVID-19(2020年4月1日至2021年11月15日)或流感(2016年至2019年)接受医院诊疗。
- 按年龄、性别、种族/族裔、婚姻状况、美国人口普查区域患者居住地、索引前可用数据年数及Elixhauser合并症评分进行1:1完整病例最近邻倾向评分匹配。
- 匹配后队列为77,272例COVID-19和77,272例流感个体,平均年龄51.0±19.7岁,57.7%为女性,41.5%为白人。
- 拟合时间至事件模型,报告COVID-19 vs 流感的风险比。
主要发现
- 与流感患者相比,COVID-19患者后续因偏头痛就诊风险较低(HR 0.645,95%CI 0.604-0.687)。
- 与流感患者相比,COVID-19患者后续因癫痫就诊风险较低(HR 0.783,95%CI 0.727-0.843)。
- 与流感患者相比,COVID-19患者后续因神经病就诊风险较低(HR 0.567,95%CI 0.532-0.604)。
- 与流感患者相比,COVID-19患者后续因运动障碍就诊风险较低(HR 0.644,95%CI 0.598-0.693)。
- 与流感患者相比,COVID-19患者后续因卒中(HR 0.904,95%CI 0.845-0.967)或痴呆(HR 0.931,95%CI 0.870-0.996)就诊风险较低。
关键数值与推荐
- 研究结局为随后一年内因偏头痛、癫痫、卒中、神经病、运动障碍和痴呆6类神经诊断的医疗就诊。
- 将6类诊断的复合作为新发事件,称为「新发神经诊断」。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Following the outbreak of viral infections from the severe acute respiratory syndrome coronavirus 2 virus in 2019 (coronavirus disease 2019 [COVID-19]), reports emerged of long-term neurologic sequelae in survivors. To better understand the burden of neurologic health care and incident neurologic diagnoses in the year after COVID-19 vs influenza, we performed an analysis of patient-level data from a large collection of electronic health records (EMR). METHODS: We acquired deidentified data from TriNetX, a global health research network providing access to EMR data. We included individuals aged 18 years or older during index event, defined as hospital-based care for COVID-19 (from April 1, 2020, until November 15, 2021) or influenza (from 2016 to 2019). The study outcomes were subsequent health care encounters over the following year for 6 neurologic diagnoses including migraine, epilepsy, stroke, neuropathy, movement disorders, and dementia. We also created a composite of the 6 diagnoses as an incident event, which we call "incident neurologic diagnoses." We performed a 1:1 complete case nearest-neighbor propensity score match on age, sex, race/ethnicity, marital status, US census region patient residence, preindex years of available data, and Elixhauser comorbidity score. We fit time-to-event models and reported hazard ratios for COVID-19 vs influenza infection. RESULTS: After propensity score matching, we had a balanced cohort of 77,272 individuals with COVID-19 and 77,272 individuals with influenza. The mean age was 51.0 ± 19.7 years, 57.7% were female, and 41.5% were White. Compared with patients with influenza, patients with COVID-19 had a lower risk of subsequent care for migraine (HR 0.645, 95% CI 0.604-0.687), epilepsy (HR 0.783, 95% CI 0.727-0.843), neuropathies (HR 0.567, 95% CI 0.532-0.604), movement disorders (HR 0.644, 95% CI 0.598-0.693), stroke (HR 0.904, 95% CI 0.845-0.967), or dementia (HR 0.931, 95% CI 0.870-0.996). Postinfection incident neurologic diagnoses were observed in 2.79% of the COVID-19 cohort vs 4.91% of the influenza cohort (HR 0.618, 95% CI 0.582-0.657). DISCUSSION: Compared with a matched cohort of adults with a hospitalization or emergency department visit for influenza infection, those with COVID-19 had significantly fewer health care encounters for 6 major neurologic diagnoses over a year of follow-up. Furthermore, we found that COVID-19 infection was associated with a lower risk of an incident neurologic diagnosis in the year after infection.
引用
- de Havenon A, Callaghan BC, Xu Y, et al. Burden of Neurologic Health Care and Incident Neurologic Diagnoses in the Year After COVID-19 or Influenza Hospitalization. Neurology. 2024. PMID: 38507675. doi:10.1212/WNL.0000000000209248
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。